Big recent buying, Stop signal 2.93. Stop signal 3.67. Break above 4.40. First Target 6.87
Great opportunity here to catch a move towards the peak of 3.
SELB filled that gap down from its data miss a few weeks back and now testing a pretty consistent level of previous support/resistance. "Selecta and IGAN Biosciences entered into a research license and option agreement to study Selecta’s ImmTOR™ immune tolerance platform in combination with IGAN’s immunoglobulin A protease for the treatment of IgA Nephropathy....
Correction complete. Breaking higher would be bullish Look for a bull break above trend line.
Phase 2 head-to-head (COMPARE) clinical trial of SEL-212 vs. KRYSTEXXA® to begin in 1Q19, interim six-month data expected in 4Q19 Collaboration with CureCN projected to dose first patient with combination of ImmTOR + AAV gene therapy candidate in 2H19 Company raises $33M in gross offering proceeds and $31.3M in net proceeds in 1Q19, cash runway into 1Q20...
Violation of multi-month channel. The support of the prior channel is now resistance. MACD is crossing down. I expect price drop to $9.